FdaApplication

ANDA 215508

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHIKMA PHARMS
application_typeANDA
approval_date2024-05-06

Products (2)

ProductActive ingredientStrengthDosage form
EDARAVONEEDARAVONE60mg/100mLINJECTION;SOLUTION
EDARAVONEEDARAVONE30MG/100ML (0.3MG/ML)SOLUTION;INTRAVENOUS

2 products